|
RPL23AP53 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.067430E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.008000E-01 |
| Normal-vs-Stage2 |
3.515600E-01 |
| Normal-vs-Stage3 |
7.332000E-01 |
| Normal-vs-Stage4 |
3.740600E-01 |
| Stage1-vs-Stage2 |
6.760200E-01 |
| Stage1-vs-Stage3 |
7.115400E-01 |
| Stage1-vs-Stage4 |
3.190600E-01 |
| Stage2-vs-Stage3 |
5.002200E-01 |
| Stage2-vs-Stage4 |
1.940620E-01 |
| Stage3-vs-Stage4 |
3.100800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.223800E-02 |
| Normal-vs-AfricanAmerican |
5.352200E-01 |
| Normal-vs-Asian |
7.194000E-02 |
| Caucasian-vs-AfricanAmerican |
2.518400E-01 |
| Caucasian-vs-Asian |
1.816110E-04 |
| AfricanAmerican-vs-Asian |
1.162420E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.892800E-01 |
| Normal-vs-Female |
2.208100E-02 |
| Male-vs-Female |
5.801600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.914600E-01 |
| Normal-vs-Extreme_Weight |
7.238400E-01 |
| Normal-vs-Obese |
9.367800E-02 |
| Normal-vs-Extreme_Obese |
5.697200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.267400E-01 |
| Normal_Weight-vs-Obese |
9.320100E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.503600E-01 |
| Extreme_Weight-vs-Obese |
1.370450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.709000E-01 |
| Obese-vs-Extreme_Obese |
8.001800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.757580E-01 |
| Normal-vs-Age(41-60Yrs) |
1.892310E-02 |
| Normal-vs-Age(61-80Yrs) |
5.361400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.218170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.490000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.263170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.019500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.497800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.076100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.405210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.785560E-02 |
| Normal-VS-Type2 PRCC |
7.236400E-02 |
| Normal-VS-KIRP CIMP |
2.559400E-01 |
| Normal-VS-Unclassified PRCC |
5.638300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.00429999994445E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.896400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.757600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.103610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.176700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.727400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.118000E-01 |
| Normal-vs-N1 |
5.164600E-01 |
| Normal-vs-N2 |
7.125200E-01 |
| N0-vs-N1 |
4.638800E-01 |
| N0-vs-N2 |
6.974000E-01 |
| N1-vs-N2 |
8.015400E-01 |
|
|
